Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids

Chinese Journal of Natural Medicines

Volumn 11, Issue 3, 2013, Pages 207-213

  Wang, Shou Bao ^a   Pang, Xiao Bin ^a   Gao, Mei ^a   Fang, Lian Hua ^a   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cerebral ischemic injury; Epoxyeicosatrienoic acids (EETs); Pinocembrin; Soluble epoxide hydrolase (sEH)

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; HYDROLASE; PINOCEMBRINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPAL CA1 REGION; IC 50; IMMUNOHISTOCHEMISTRY; MALE; NEUROLOGIC DISEASE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; WESTERN BLOTTING;

EID: 84878448382     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60018-7     Document Type: Article

References (29)

1. Zhang JY, Yan GT, Liao J, et al. Leptin attenuates cerebral ischemia/reperfusion injury partially by CGRP expression [J]. Eur J Pharmacol 2011, 671(1-3):61-69.
2. Feigin VL, Lawes CM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century [J]. Lancet Neurol 2003, 2(1):43-53.
3. Dorrance AM, Rupp N, Pollock DM, et al. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido) dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats [J]. J Cardiovasc Pharmacol 2005, 46(6):842-848.
4. Simpkins AN, Rudic RD, Schreihofer DA, et al. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection [J]. Am J Pathol 2009, 174(6):2086-2095.
5. Zhang W, Koerner IP, Noppens R, et al. Soluble epoxide hydrolase: a novel therapeutic target in stroke [J]. J Cereb Blood Flow Metab 2007, 27(12):1931-1940.
6. Bremner PD, Meyer JJ Pinocembrin chalcone: an antibacterial compound from Helichrysum trilineatum [J]. Planta Med 1998, 64(8):777.
7. Gao M, Zhang WC, Liu QS, et al. Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio [J]. Eur J Pharmacol 2008, 591(1-3):73-79.
8. Lee MY, Seo CS, Lee JA, et al. Alpinia katsumadai Hayata seed extract inhibits LPS-induced inflammation by induction of heme oxygenase-1 in RAW264.7 cells [J]. Inflammation 2011, 35(2):746-757.
9. Jaganathan SK, Mandal M Antiproliferative effects of honey and of its polyphenols: a review [J]. J Biomed Biotechnol 2009, 2009:830616.
10. Zhu XM, Fang LH, Li YJ, et al. Endothelium-dependent and -independent relaxation induced by pinocembrin in rat aortic rings [J]. Vascul Pharmacol 2007, 46(3):160-165.
11. Shi LL, Chen BN, Gao M, et al. The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats [J]. Life Sci 2011, 88(11-12):521-528.
12. Gao M, Zhu SY, Tan CB, et al. Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats [J]. J Asian Nat Prod Res 2010, 12(5):407-418.
13. Guang HM, Du GH Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats [J]. Eur J Pharmacol 2006, 542(1-3):77-83.
14. Meng F, Liu R, Gao M, et al. Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats [J]. Brain Res 2011, (1391):93-101.
15. Shi LL, Qiang GF, Gao M, et al. Effect of pinocembrin on brain mitochondrial respiratory function [J]. Acta Pharm Sin 2011, 46(6):642-649.
16. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke 1989, 20(1):84-91.
17. Wolf NM, Morisseau C, Jones PD, et al. Development of a high-throughput screen for soluble epoxide hydrolase inhibition [J]. Anal Biochem 2006, 355(1):71-80.
18. Wang SB, Guo J, Yu XM, et al. High-throughput screening of human soluble epoxide hydrolase inhibitors [J]. Acta Pharm Sin 2010, 45(11):1367-1372.
19. Gao M, Liu R, Zhu SY, et al. Acute neurovascular unit protective action of pinocembrin against permanent cerebral ischemia in rats [J]. J Asian Nat Prod Res 2008, 10(5-6):551-558.
20. Liu R, Gao M, Yang ZH, et al. Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro [J]. Brain Res 2008, (1216):104-115.
21. Spector AA, Norris AW Action of epoxyeicosatrienoic acids on cellular function [J]. Am J Physiol Cell Physiol 2007, 292(3):C996-1012.
22. Wang Y, Wei X, Xiao X, et al. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways [J]. J Pharmacol Exp Ther 2005, 314(2):522-532.
23. Spector AA, Fang X, Snyder GD, et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function [J]. Prog Lipid Res 2004, 43(1):55-90.
24. Zhang W, Otsuka T, Sugo N, et al. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia [J]. Stroke 2008, 39(7):2073-2078.
25. Fornage M, Lee CR, Doris PA, et al. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke [J]. Hum Mol Genet 2005, 14(19):2829-2837.
26. Gschwendtner A, Ripke S, Freilinger T, et al. Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans [J]. Stroke 2008, 39(5):1593-1596.
27. Zhang L, Ding H, Yan J, et al. Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population [J]. Pharmacogenet Genomics 2008, 18(1):45-51.
28. Butler TL, Kassed CA, Sanberg PR, et al. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion [J]. Brain Res 2002, 929(2):252-260.
29. Chang HS, Sasaki T, Kassell NF Hippocampal unit activity after transient cerebral ischemia in rats [J]. Stroke 1989, 20(8):1051-1058.